Hwasun Immunotherapy Summit 2019
Date : Day 2 Nov. 8(Fri)
| Time | Contents | Speaker |
|---|---|---|
| 09:25 ~ 09:30 | Opening Remarks | |
| 09:30 ~ 12:10 | Session 1. New Horizon in Immunotherapy | |
| 09:30 ~ 10:05 | The Revolution in Synthetic Nucleics – Invivo Generation of sDNA Encoded Biologics | David Weiner Executive vice president, Wistar Institute |
| 10:05 ~ 10:30 | Current Status and Future Prospects of Microbiome-targeted Therapeutics | Sin-Hyeog Im Professor, POSTECH |
| 10:30 ~ 10:55 | Exogenous inducer-free expression of a genetically encoded anticancer drug by a quorum-sensing system in tumor-targeting Salmonella | Hyon E. Choy Professor, Combinatorial Tumor Immunotherapy MRC, Chonnam National University Medical School |
| 10:55 ~ 11:20 | Cancer cell targeting using EphA2-specific monobody | Yeongjin Hong Professor, Combinatorial Tumor Immunotherapy MRC, Chonnam National University Medical School |
| 11:20 ~ 11:45 | Let PLA/PLGA particle work more efficiently as a vaccine “Chassis”(adjuvant) | Guanghui Ma Professor, National key Laboratory of Biochemical Engineering |
| 11:45 ~ 12:10 | Catalase Mimicking Nanopods Targeting Tumor Adaptation to Hypoxia Potentiate Image-guided Photothermal Therapy | In-Kyu Park Professor, Combinatorial Tumor Immunotherapy MRC, Chonnam National University Medical School |
| 12:10 ~ 13:10 | Lunch | |
| 13:10 ~ 15:15 | Session 2. Cell-based cancer immunotherapy: present and future | |
| 13:10 ~ 13:35 | Competition and Challenges in the Space of BCMA Targeted Immunotherapy, towards the cure of multiple myeloma? | Frank Fan Chief scientific officer, Nanjing Legend Biotechnology |
| 13:35 ~ 14:00 | Using armoured CAR T cells to promote epitope spreading and elimination of antigen negative tumour cells | Paul Beavis Group leader, Peter MacCallum Cancer Center |
| 14:00 ~ 14:25 | Development of CeliVax, B cell & monocyte-based cancer therapeutic vaccine | Chang-Yuil Kang CEO, CELLID |
| 14:25 ~ 14:50 | Recent developments of NK cell therapy |
Sung Yoo Cho Director, Green Cross LabCell |
| 14:50 ~ 15:15 | An Effective Peptide-based Vaccination strategy for Cancer Immunotherapy |
Cho, Hyun-Il Director, ViGenCell |
| 15:15 ~ 15:35 | Coffee Break | |
| 15:35 ~ 17:40 | Session 3. Developments and applications in cancer immunotherapy | |
| 15:35 ~ 16:00 | Vaxleukin-15 Cancer Immunotherapy in Companion Animals: A Steppingstone towards Human Application | Sangki Kim Consultant, VaxCell Biotherapeutics |
| 16:00 ~ 16:25 | Combination of autologous natural killer cells with hepatic arterial infusion chemotherapy in hepatocellular carcinoma | Woo Kyun Bae Professor, Combinatorial Tumor Immunotherapy MRC, Chonnam National University Medical School |
| 16:25 ~ 16:50 | Development of Dendritic cell-based Next Generation Cancer Therapeutic Vaccine | Hyuna Lee Research Director, Pharmicell Co., Ltd |
| 16:50 ~ 17:15 | Development of ImmunCell-LC |
Jong-Seong Ahn Director, Green Cross Cell corp. |
| 17:15 ~ 17:40 | Flagellin-adjuvanted cancer vaccine strategy | Joon Haeng Rhee Professor, Combinatorial Tumor Immunotherapy MRC, Chonnam National University Medical School |
| 17:40 ~ 17:45 | Closing Remarks | |